|
1
|
Zadeh-Vakili A, Ramezani Tehrani F,
Daneshpour MS, Zarkesh M, Saadat N and Azizi F: Genetic
polymorphism of vitamin D receptor gene affects the phenotype of
PCOS. Gene. 515:193–196. 2013. View Article : Google Scholar
|
|
2
|
Carmina E and Lobo RA: Polycystic ovary
syndrome (PCOS): arguably the most common endocrinopathy is
associated with significant morbidity in women. J Clin Endocrinol
Metab. 84:1897–1899. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Futterweit W: Polycystic ovary syndrome:
Clinical perspectives and management. Obstet Gynecol Surv.
54:403–413. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group: Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome. Fertil Steril. 81:19–25. 2004. View Article : Google Scholar
|
|
5
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group: Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome (PCOS). Hum Reprod. 19:41–47. 2004. View Article : Google Scholar
|
|
6
|
Qiao J and Feng HL: Extra- and
intra-ovarian factors in polycystic ovary syndrome: impact on
oocyte maturation and embryo developmental competence. Hum Reprod
Update. 17:17–33. 2011. View Article : Google Scholar
|
|
7
|
Tal R, Seifer DB, Shohat-Tal A, Grazi RV
and Malter HE: Transforming growth factor-beta1 and its receptor
soluble endoglin are altered in polycystic ovary syndrome during
controlled ovarian stimulation. Fertil Steril. 100:538–543. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Diamanti-Kandarakis E, Kandarakis H and
Legro RS: The role of genes and environment in the etiology of
PCOS. Endocrine. 30:19–26. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dantas WS, Gualano B, Rocha MP, Barcellos
CR, dos Reis Vieira Yance V and Marcondes JA: Metabolic disturbance
in PCOS: clinical and molecular effects on skeletal muscle tissue.
Scientific World J. 2013:1783642013.
|
|
10
|
Doi SA, Towers PA, Scott CJ and Al-Shoumer
KA: PCOS: an ovarian disorder that leads to dysregulation in the
hypothalamic-pituitary-adrenal axis? Eur J Obstet Gynecol Reprod
Biol. 118:4–16. 2005. View Article : Google Scholar
|
|
11
|
Ehrmann DA: Metabolic dysfunction in pcos:
Relationship to obstructive sleep apnea. Steroids. 77:290–294.
2012. View Article : Google Scholar
|
|
12
|
Luque-Ramírez M, San Millán JL and
Escobar-Morreale HF: Genomic variants in polycystic ovary syndrome.
Clin Chim Acta. 366:14–26. 2006. View Article : Google Scholar
|
|
13
|
Urbanek M, Woodroffe A, Ewens KG, et al:
Candidate gene region for polycystic ovary syndrome on chromosome
19p13.2. J Clin Endocrinol Metab. 90:6623–6629. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stewart DR, Dombroski BA, Urbanek M, et
al: Fine mapping of genetic susceptibility to polycystic ovary
syndrome on chromosome 19p13.2 and tests for regulatory activity. J
Clin Endocrinol Metab. 91:4112–4117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jordan CD, Bohling SD, Charbonneau NL and
Sakai LY: Fibrillins in adult human ovary and polycystic ovary
syndrome: is fibrillin-3 affected in PCOS? J Histochem Cytochem.
58:903–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Letterio JJ and Roberts AB: Regulation of
immune responses by TGF-beta. Annu Rev Immunol. 16:137–161. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Govinden R and Bhoola KD: Genealogy,
expression and cellular function of transforming growth
factor-beta. Pharmacol Ther. 98:257–265. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taipale J, Saharinen J and Keski-Oja J:
Extracellular matrix-associated transforming growth factor-beta:
role in cancer cell growth and invasion. Adv Cancer Res. 75:87–134.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ten Dijke P and Hill CS: New insights into
TGF-beta-Smad signalling. Trends Biochem Sci. 29:265–273. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bachman KE and Park BH: Duel nature of
TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Opin
Oncol. 17:49–54. 2005. View Article : Google Scholar
|
|
21
|
Moustakas A, Souchelnytskyi S and Heldin
CH: Smad regulation in TGF-beta signal transduction. J Cell Sci.
114:4359–4369. 2001.
|
|
22
|
Massagué J: How cells read TGF-beta
signals. Nat Rev Mol Cell Biol. 1:169–178. 2000. View Article : Google Scholar
|
|
23
|
Shi Y and Massague J: Mechanisms of
TGF-beta signaling from cell membrane to the nucleus. Cell.
113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
König HG, Kögel D, Rami A and Prehn JH:
TGF-{beta}1 activates two distinct type I receptors in neurons:
implications for neuronal NF-{kappa}B signaling. J Cell Biol.
168:1077–1086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Caraci F, Battaglia G, Busceti C, et al:
TGF-beta 1 protects against Abeta-neurotoxicity via the
phosphatidylinositol-3-kinase pathway. Neurobiol Dis. 30:234–242.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu Y, Culmsee C, Klumpp S and Krieglstein
J: Neuroprotection by transforming growth factor-beta1 involves
activation of nuclear factor-kappaB through
phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein
kinase-extracellular-signal regulated kinase1, 2 signaling
pathways. Neuroscience. 123:897–906. 2004. View Article : Google Scholar
|
|
28
|
Bosco P, Ferri R, Salluzzo MG, et al: Role
of the transformin g-growth-factor-beta1 gene in late-onset
Alzheimer's disease: implications for the treatment. Curr Genomics.
14:147–156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sproul K, Jones MR, Mathur R, Azziz R and
Goodarzi MO: Association study of four key folliculogenesis genes
in polycystic ovary syndrome. BJOG. 117:756–760. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Welt CK, Taylor AE, Fox J, Messerlian GM,
Adams JM and Schneyer AL: Follicular arrest in polycystic ovary
syndrome is associated with deficient inhibin A and B biosynthesis.
J Clin Endocrinol Metab. 90:5582–5587. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eldar-Geva T, Spitz IM, Groome NP,
Margalioth EJ and Homburg R: Follistatin and activin A serum
concentrations in obese and non-obese patients with polycystic
ovary syndrome. Hum Reprod. 16:2552–2556. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hatzirodos N, Bayne RA, Irving-Rodgers HF,
et al: Linkage of regulators of TGF-beta activity in the fetal
ovary to polycystic ovary syndrome. FASEB J. 25:2256–2265. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Akai Y, Sato H, Ozaki H, Iwano M, Dohi Y
and Kanauchi M: Association of transforming growth factor-beta1
T29C polymorphism with the progression of diabetic nephropathy. Am
J Kidney Dis. 38(4 Suppl 1): 182–185. 2001. View Article : Google Scholar
|
|
34
|
Peng Z, Zhan L, Chen S and Xu E:
Association of transforming growth factor-beta1 gene C-509T and
T869C polymorphisms with atherosclerotic cerebral infarction in the
Chinese: a case-control study. Lipids Health Dis. 10:1002011.
View Article : Google Scholar
|
|
35
|
Jia H, Yu L, Gao B and Ji Q: Association
between the T869C polymorphism of transforming growth factor-beta 1
and diabetic nephropathy: a meta-analysis. Endocrine. 40:372–378.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
El-Sherbini SM, Shahen SM, Mosaad YM,
Abdelgawad MS and Talaat RM: Gene polymorphism of transforming
growth factor-beta1 in Egyptian patients with type 2 diabetes and
diabetic nephropathy. Acta Biochim Biophys Sin (Shanghai).
45:330–338. 2013. View Article : Google Scholar
|
|
37
|
Hou YL, Chen H, Dong ZH, et al: Clinical
significance of serum transforming growth factor-beta1 in lung
cancer. Cancer Epidemiol. 37:750–753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shah R, Rahaman B, Hurley CK and Posch PE:
Allelic diversity in the TGFB1 regulatory region: characterization
of novel functional single nucleotide polymorphisms. Hum Genet.
119:61–74. 2006. View Article : Google Scholar
|
|
39
|
Awad MR, El-Gamel A, Hasleton P, Turner
DM, Sinnott PJ and Hutchinson IV: Genotypic variation in the
transforming growth factor-beta1 gene: association with
transforming growth factor-beta1 production, fibrotic lung disease
and graft fibrosis after lung transplantation. Transplantation.
66:1014–1020. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sharma K and Ziyadeh FN: The emerging role
of transforming growth factor-beta in kidney diseases. Am J
Physiol. 266:F829–F842. 1994.PubMed/NCBI
|
|
41
|
Border WA and Noble NA: Transforming
growth factor beta in tissue fibrosis. N Engl J Med. 331:1286–1292.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Trombly DJ, Woodruff TK and Mayo KE: Roles
for transforming growth factor beta superfamily proteins in early
folliculogenesis. Semin Reprod Med. 27:14–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Raja-Khan N, Kunselman AR, Demers LM,
Ewens KG, Spielman RS and Legro RS: A variant in the fibrillin-3
gene is associated with TGF-beta and inhibin B levels in women with
polycystic ovary syndrome. Fertil Steril. 94:2916–2919. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Raja-Khan N, Urbanek M, Rodgers RJ and
Legro RS: The role of TGF-beta in polycystic ovary syndrome. Reprod
Sci. 21:20–31. 2014. View Article : Google Scholar
|
|
45
|
Dumesic DA and Abbott DH: Implications of
polycystic ovary syndrome on oocyte development. Semin Reprod Med.
26:53–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Buraczynska M, Baranowicz-Gaszczyk I,
Borowicz E and Ksiazek A: TGF-beta1 and TSC-22 gene polymorphisms
and susceptibility to microvascular complications in type 2
diabetes. Nephron Physiol. 106:p69–p75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wong TY, Poon P, Chow KM, Szeto CC, Cheung
MK and Li PK: Association of transforming growth factor-beta
(TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2
diabetic nephropathy in Chinese. Kidney Int. 63:1831–1835. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li MO, Wan YY, Sanjabi S, Robertson AK and
Flavell RA: Transforming growth factor-beta regulation of immune
responses. Annu Rev Immunol. 24:99–146. 2006. View Article : Google Scholar : PubMed/NCBI
|
